FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...